CoChat

Bordetella Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells

Open access
Ahmad, Jawid Nazir, Holubova, Jana, Benada, Oldrich, Kofronova, Olga, Stehlik, Ludek, Vasakova, Martina, Sebo, Peter · 2019 · mBio

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Macrophages are key sentinel cells of the immune system, and, as such, they are targeted by the toxins produced by the pertussis agent Bordetella pertussis . The adenylate cyclase toxin (CyaA) mediates immune evasion of B. pertussis by suspending the bactericidal activities of myeloid phagocytes. We reveal a novel mechanism of potential subversion of host immunity, where CyaA at very low (22 pM) concentrations could inhibit maturation of human monocyte precursors into the more phagocytic macrophage cells. Furthermore, exposure to low CyaA amounts has been shown to trigger dedifferentiation of mature primary human alveolar macrophages back into monocyte-like cells. This unprecedented capacity is likely to promote survival of the pathogen in the airways, both by preventing maturation of monocytes attracted to the site of infection into phagocytic macrophages and by dedifferentiation of the already airway-resident sentinel cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.01743-19

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 CyaA subverts monocyte differentiation and acquisition of macrophage-defining cellular features. (A) Schematic representation of the experimental procedure for the analysis of CyaA toxin effects on monocyte differentiation. CD14+ monocytes were cultured in DMEM–20 ng/ml M-CSF for 5 days and subjected to mock treatment or exposed for 5 days to 4 ng/ml (22.5 pM) CyaA or to the corresponding noncatalytic CyaA-AC− toxoid, freshly added with every medium change at 24-h intervals. (B) Transmission electron microscopy analysis of the size, pseudopodium production and intracellular organelle accumulation, and complexity of cells after 5 days of differentiation culture with M-CSF. Images are representative of several dozens of cell images inspected for each condition. The CyaA-treated monocytes remained round and small, with no pseudopodia and with reduced organelle content, compared to the mock-treated cells (Control) or toxoid-treated cells (CyaA-AC−), which matured into macrophage cells producing numerous pseudopodia and exhibited a high organelle complexity. (C) Cell size and granularity determined by FACS analysis. The low level of side scatter (SSC) corresponds to smaller cell sizes and reduced intracellular organelle complexity. The histogram shown is representative of results from 10 biological replicates.
FIG 1 CyaA subverts monocyte differentiation and acquisition of macrophage-defining cellular features. (A) Schematic representation of the experimental procedure for the analysis of CyaA toxin effects on monocyte differentiation. CD14+ monocytes were cultured in DMEM–20 ng/ml M-CSF for 5 days and subjected to mock treatment or exposed for 5 days to 4 ng/ml (22.5 pM) CyaA or to the corresponding noncatalytic CyaA-AC− toxoid, freshly added with every medium change at 24-h intervals. (B) Transmission electron microscopy analysis of the size, pseudopodium production and intracellular organelle accumulation, and complexity of cells after 5 days of differentiation culture with M-CSF. Images are representative of several dozens of cell images inspected for each condition. The CyaA-treated monocytes remained round and small, with no pseudopodia and with reduced organelle content, compared to the mock-treated cells (Control) or toxoid-treated cells (CyaA-AC−), which matured into macrophage cells producing numerous pseudopodia and exhibited a high organelle complexity. (C) Cell size and granularity determined by FACS analysis. The low level of side scatter (SSC) corresponds to smaller cell sizes and reduced intracellular organelle complexity. The histogram shown is representative of results from 10 biological replicates.CC BY · PubMed Central
FIG 2 CyaA toxin activity subverts M-CSF-elicited monocyte-macrophage transition. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF and 22.5 pM CyaA or CyaA-AC− (A) FACS analysis of relative levels of cell surface expression of macrophage markers. The median fluorescence intensity (MFI) values shown represent means ± standard deviations (SD). n = ≥7; **, P < 0.05; ***, P < 0.0005. (B) qPCR analysis of transcript levels of macrophage marker genes. The fold change values are means ± SD, n ≥ 7 biological replicates performed in duplicates; ***, P < 0.0005. (C) CyaA inhibits downregulation of CD14 marker expression on monocytes. Levels of the CD14 marker protein in cellular lysates were analyzed by densitometry of immunoblots of whole-cell lysates and expressed as fold change, assigning the CD14 level of mock-treated cells a value of 1. The values were normalized to the β-actin protein level used as a loading control. Values are means ± SD, n = 3; *, P < 0.05. (D) Cell surface expression of CD14 detected by flow cytometry. (E) CD14+ monocytes were infected by wild-type and mutant strains of B. pertussis CIP 81.32 Tohama I at MOI 2:1 for the first 12 h of culture. Bacteria were next killed by the use of 50 μg/ml polymyxin B plus 50 μg/ml kanamycin for an additional 12 h. At 5 days later, after repeated medium replacement, the expression levels of macrophage markers were analyzed by flow cytometry. (F) CD14+ monocytes were treated as described above, and surface expression levels of the CD14 marker were determined by flow cytometry. The MFI values are indicated as means ± SD, n ≥ 3 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.
FIG 2 CyaA toxin activity subverts M-CSF-elicited monocyte-macrophage transition. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF and 22.5 pM CyaA or CyaA-AC− (A) FACS analysis of relative levels of cell surface expression of macrophage markers. The median fluorescence intensity (MFI) values shown represent means ± standard deviations (SD). n = ≥7; **, P < 0.05; ***, P < 0.0005. (B) qPCR analysis of transcript levels of macrophage marker genes. The fold change values are means ± SD, n ≥ 7 biological replicates performed in duplicates; ***, P < 0.0005. (C) CyaA inhibits downregulation of CD14 marker expression on monocytes. Levels of the CD14 marker protein in cellular lysates were analyzed by densitometry of immunoblots of whole-cell lysates and expressed as fold change, assigning the CD14 level of mock-treated cells a value of 1. The values were normalized to the β-actin protein level used as a loading control. Values are means ± SD, n = 3; *, P < 0.05. (D) Cell surface expression of CD14 detected by flow cytometry. (E) CD14+ monocytes were infected by wild-type and mutant strains of B. pertussis CIP 81.32 Tohama I at MOI 2:1 for the first 12 h of culture. Bacteria were next killed by the use of 50 μg/ml polymyxin B plus 50 μg/ml kanamycin for an additional 12 h. At 5 days later, after repeated medium replacement, the expression levels of macrophage markers were analyzed by flow cytometry. (F) CD14+ monocytes were treated as described above, and surface expression levels of the CD14 marker were determined by flow cytometry. The MFI values are indicated as means ± SD, n ≥ 3 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.CC BY · PubMed Central
FIG 3 CyaA-produced cAMP signaling mediated through the activity of PKA subverts monocyte-macrophage transition. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF and 22.5 pM CyaA or CyaA-AC− or with the indicated compounds at the given concentrations. (A and B) Suppression of the macrophage marker gene and of surface protein expression depends on the cAMP-producing AC enzyme activity of CyaA. The values are means ± SD, n ≥ 7; **, P < 0.005; ***, P < 0.0005. (C) The cell-permeative and PKA-specific activator 6-Bnz-cAMP (100 μM) suppresses CD36 and CD68 expression to the same level as the cAMP-elevating activity of 22.5 pM CyaA. The CD36 and CD68 proteins were detected by immunoblotting of whole-cell lysates, and their levels were normalized to that of the β-actin loading control. (D) The cell-permeative and PKA-selective inhibitor Rp-8-Br-cAMPS (0.5 mM) blocked CyaA-elicited downregulation of macrophage cell surface markers, whereas the PKA-selective activator 6-Bnz-cAMP (100 μM) mimicked CyaA toxin action and inhibited macrophage marker expression. The values are means ± SD, n ≥ 3 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.
FIG 3 CyaA-produced cAMP signaling mediated through the activity of PKA subverts monocyte-macrophage transition. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF and 22.5 pM CyaA or CyaA-AC− or with the indicated compounds at the given concentrations. (A and B) Suppression of the macrophage marker gene and of surface protein expression depends on the cAMP-producing AC enzyme activity of CyaA. The values are means ± SD, n ≥ 7; **, P < 0.005; ***, P < 0.0005. (C) The cell-permeative and PKA-specific activator 6-Bnz-cAMP (100 μM) suppresses CD36 and CD68 expression to the same level as the cAMP-elevating activity of 22.5 pM CyaA. The CD36 and CD68 proteins were detected by immunoblotting of whole-cell lysates, and their levels were normalized to that of the β-actin loading control. (D) The cell-permeative and PKA-selective inhibitor Rp-8-Br-cAMPS (0.5 mM) blocked CyaA-elicited downregulation of macrophage cell surface markers, whereas the PKA-selective activator 6-Bnz-cAMP (100 μM) mimicked CyaA toxin action and inhibited macrophage marker expression. The values are means ± SD, n ≥ 3 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.CC BY · PubMed Central
FIG 4 CyaA blocks upregulation of phagocytic capacity. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF and 22.5 pM CyaA or CyaA-AC− or the indicated compounds at the given concentrations. (A and B) Exposure to 4 ng/ml (22.5 pM) CyaA (A) or infection with the B. pertussis WT strain (B. pertussis AC+ PT+) (B) for 12 h at an MOI of 2:1 suppressed the differentiation-induced increase in the ability to phagocytose serum-opsonized 0.75-μm-diameter fluorescent phagobeads. n ≥ 4; **, P < 0.05; ***, P < 0.005. (C to E) CyaA (22.5 pM)-elicited cAMP signaling inhibited expression of phagocytic receptors FcγRI (C) and FcγRIII (D), and this inhibition was relieved by the activity of PKA-selective inhibitor Rp-8-Br-cAMPS (0.5 mM) (E). n ≥ 3 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.
FIG 4 CyaA blocks upregulation of phagocytic capacity. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF and 22.5 pM CyaA or CyaA-AC− or the indicated compounds at the given concentrations. (A and B) Exposure to 4 ng/ml (22.5 pM) CyaA (A) or infection with the B. pertussis WT strain (B. pertussis AC+ PT+) (B) for 12 h at an MOI of 2:1 suppressed the differentiation-induced increase in the ability to phagocytose serum-opsonized 0.75-μm-diameter fluorescent phagobeads. n ≥ 4; **, P < 0.05; ***, P < 0.005. (C to E) CyaA (22.5 pM)-elicited cAMP signaling inhibited expression of phagocytic receptors FcγRI (C) and FcγRIII (D), and this inhibition was relieved by the activity of PKA-selective inhibitor Rp-8-Br-cAMPS (0.5 mM) (E). n ≥ 3 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.CC BY · PubMed Central
FIG 5 CyaA-elicited cAMP signaling triggers dedifferentiation of fully differentiated macrophages. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF to induce differentiation into macrophages before 22.5 pM CyaA or CyaA-AC− was added, and the culture with 20 ng/ml M-CSF was continued for another 5 days in the presence of CyaA toxin. (A) Schematic depiction of the design of the dedifferentiation experiment. (B) Flow cytometry analysis of cell surface expression of macrophage markers on macrophages exposed for 5 days to CyaA or the indicated compounds. The cell-permeative and PKA-specific activator 6-Bnz-cAMP (1 mM) effectively elicited macrophage dedifferentiation. PKA inhibitor Rp-8-Br-cAMPS (1 mM) partially blocked CyaA toxin-triggered macrophage dedifferentiation. (C) Phase-contrast microscopy images of macrophages that were first differentiated for 5 days with 20 ng/ml M-CSF and then exposed for another 5 days to 22.5 pM CyaA toxin or CyaA-AC− toxoid in the continued presence of 20 ng/ml M-CSF. The shown images are representative of several dozens of images taken in 3 independent experiments (biological replicates). Bar, 20 μm. (D) CyaA-elicited cAMP signaling upregulated CD14 expression in M-CSF-matured macrophages. CyaA-AC− toxoid or mock-treated control cells maintained the CD14low phenotype of differentiated macrophages over 5 days of culture. Upon exposure of M-CSF-differentiated macrophages to the PKA-specific activator 6-Bnz-cAMP (1 mM), the CD14 expression level was upregulated. Exposure to the PKA inhibitor Rp-8-Br-cAMPS (1 mM) did not fully block CyaA toxin-triggered upregulation of CD14. *, P < 0.05; **, P < 0.005; ***, P < 0.0005. (E) M-CSF-differentiated macrophages lost intracellular complexity upon treatment with 22.5 pM CyaA or 1 mM PKA-specific activator 6-Bnz-cAMP for 5 days, as observed by low side scatter. Control and CyaA-AC−-exposed cells retained complex cytoplasm rich in cellular organelles. (F) M-CSF-differentiated macrophages were infected by wild-type and mutant strains of B. pertussis CIP 81.32 Tohama I at MOI of 2:1 for the first 12 h of culture. Bacteria were killed by the use of 50 μg/ml polymyxin B plus 50 μg/ml kanamycin over additional 12 h of incubation. 5 days later, after repeated medium replacement, the expression levels of macrophage markers was analyzed by flow cytometry. n = 3 biological replicates; *, P < 0.05; **, P < 0.005; #, above range. (G) Phase-contrast microscopy analysis of cell shape and appearance of mature macrophage cells after 5 days of dedifferentiation resulting following infection with B. pertussis for 12 h at MOI 2:1. Macrophages were first allowed to mature for 5 days with 20 ng/ml M-CSF in DMEM. Next, the macrophage cells were infected with the wild-type strain or the indicated mutant strains of B. pertussis CIP 81.32 Tohama I at MOI of 2:1 for 12 h. The bacteria were then killed with 50 μg/ml polymyxin B plus 50 μg/ml kanamycin over 12 h. The cells were further cultured for 5 days in DMEM–20 ng/ml M-CSF, with half of the media being replenished with fresh medium. After 5 days postinfection, cells were visualized by phase-contrast microscopy, where the macrophage cells exhibited altered morphology, drastic cell shrinkage, and reduced adherence to the surface of the plastic. The shown images are representative of several dozens of images taken on 3 biological replicates. Bar, 20 μm.
FIG 5 CyaA-elicited cAMP signaling triggers dedifferentiation of fully differentiated macrophages. CD14+ monocytes were cultured for 5 days in DMEM–20 ng/ml M-CSF to induce differentiation into macrophages before 22.5 pM CyaA or CyaA-AC− was added, and the culture with 20 ng/ml M-CSF was continued for another 5 days in the presence of CyaA toxin. (A) Schematic depiction of the design of the dedifferentiation experiment. (B) Flow cytometry analysis of cell surface expression of macrophage markers on macrophages exposed for 5 days to CyaA or the indicated compounds. The cell-permeative and PKA-specific activator 6-Bnz-cAMP (1 mM) effectively elicited macrophage dedifferentiation. PKA inhibitor Rp-8-Br-cAMPS (1 mM) partially blocked CyaA toxin-triggered macrophage dedifferentiation. (C) Phase-contrast microscopy images of macrophages that were first differentiated for 5 days with 20 ng/ml M-CSF and then exposed for another 5 days to 22.5 pM CyaA toxin or CyaA-AC− toxoid in the continued presence of 20 ng/ml M-CSF. The shown images are representative of several dozens of images taken in 3 independent experiments (biological replicates). Bar, 20 μm. (D) CyaA-elicited cAMP signaling upregulated CD14 expression in M-CSF-matured macrophages. CyaA-AC− toxoid or mock-treated control cells maintained the CD14low phenotype of differentiated macrophages over 5 days of culture. Upon exposure of M-CSF-differentiated macrophages to the PKA-specific activator 6-Bnz-cAMP (1 mM), the CD14 expression level was upregulated. Exposure to the PKA inhibitor Rp-8-Br-cAMPS (1 mM) did not fully block CyaA toxin-triggered upregulation of CD14. *, P < 0.05; **, P < 0.005; ***, P < 0.0005. (E) M-CSF-differentiated macrophages lost intracellular complexity upon treatment with 22.5 pM CyaA or 1 mM PKA-specific activator 6-Bnz-cAMP for 5 days, as observed by low side scatter. Control and CyaA-AC−-exposed cells retained complex cytoplasm rich in cellular organelles. (F) M-CSF-differentiated macrophages were infected by wild-type and mutant strains of B. pertussis CIP 81.32 Tohama I at MOI of 2:1 for the first 12 h of culture. Bacteria were killed by the use of 50 μg/ml polymyxin B plus 50 μg/ml kanamycin over additional 12 h of incubation. 5 days later, after repeated medium replacement, the expression levels of macrophage markers was analyzed by flow cytometry. n = 3 biological replicates; *, P < 0.05; **, P < 0.005; #, above range. (G) Phase-contrast microscopy analysis of cell shape and appearance of mature macrophage cells after 5 days of dedifferentiation resulting following infection with B. pertussis for 12 h at MOI 2:1. Macrophages were first allowed to mature for 5 days with 20 ng/ml M-CSF in DMEM. Next, the macrophage cells were infected with the wild-type strain or the indicated mutant strains of B. pertussis CIP 81.32 Tohama I at MOI of 2:1 for 12 h. The bacteria were then killed with 50 μg/ml polymyxin B plus 50 μg/ml kanamycin over 12 h. The cells were further cultured for 5 days in DMEM–20 ng/ml M-CSF, with half of the media being replenished with fresh medium. After 5 days postinfection, cells were visualized by phase-contrast microscopy, where the macrophage cells exhibited altered morphology, drastic cell shrinkage, and reduced adherence to the surface of the plastic. The shown images are representative of several dozens of images taken on 3 biological replicates. Bar, 20 μm.CC BY · PubMed Central
FIG 6 CyaA dedifferentiates human alveolar macrophages. (A) Scheme of the experiment. Alveolar macrophages obtained from human bronchoalveolar lavage (BAL) fluid samples were treated with 4 ng/ml (22.5 pM) or 8 ng/ml (45 pM) of CyaA for 5 days in the presence of M-CSF. (B and C) Macrophage markers (B) and CD14 cell surface expression (C) were analyzed by flow cytometry. n = 5 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.
FIG 6 CyaA dedifferentiates human alveolar macrophages. (A) Scheme of the experiment. Alveolar macrophages obtained from human bronchoalveolar lavage (BAL) fluid samples were treated with 4 ng/ml (22.5 pM) or 8 ng/ml (45 pM) of CyaA for 5 days in the presence of M-CSF. (B and C) Macrophage markers (B) and CD14 cell surface expression (C) were analyzed by flow cytometry. n = 5 biological replicates; *, P < 0.05; **, P < 0.005; ***, P < 0.0005.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 38

Metadata

Authors
Ahmad, J. N., Holubova, J., Benada, O., Kofronova, O., Stehlik, L., Vasakova, M., & Sebo, P.
Affiliations
  • Czech Academy of Sciences (CZ)
  • Laboratory of Molecular Biology of Bacterial Pathogens, Institute of Microbiology of the CAS, Prague, Czech Republic
  • Laboratory of Molecular Structure Characterization, Institute of Microbiology of the CAS, Prague, Czech Republic
  • Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic
Corresponding author
Ahmad, Jawid Nazir
Venue
mBio
Published
2019-10-29
Volume
10
Issue
5
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2975351022
Cited by
38
References
54
Citations by year
2026: 5 · 2025: 5 · 2024: 6 · 2023: 1 · 2022: 10 · 2021: 6 · 2020: 5
FWCI
3.87
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Czech Science Foundation (19-27630X)
  • Agency for Health Research of the Czech Republic (NV16-28126A)
  • Ministry of Education, Youth and Sports of the Czech Republic (LO1509)
  • Ministry of Education, Youth and Sports of the Czech Republic - EATRIS-CZ (CZ.02.1.01/0.0/0.0/16_013/0001818)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
Bordetella pertussis, adenylate cyclase toxin, monocyte-to-macrophage differentiation, alveolar macrophages, monocyte-like cells, immune evasion, pertussis, phagocytosis
MeSH terms
Bordetella pertussis, Cell Differentiation, Humans, Monocytes, Macrophages, Alveolar, Adenylate Cyclase Toxin, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bordetella Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells. https://app.cochat.ai/papers/10.1128/mbio.01743-19
The paper
Ahmad, J. N., Holubova, J., Benada, O., Kofronova, O., Stehlik, L., Vasakova, M., & Sebo, P. (2019). Bordetella Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells. mBio. https://doi.org/10.1128/mbio.01743-19

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.